Terazosin

Product NDC

0615-1338

11-digit product format

006151338

Labeler code

0615

Product ID

0615-1338_8dcbb073-d3d6-4c00-9e59-6edb07d2c144

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Terazosin

Dosage form

CAPSULE

Route

ORAL

Labeler

NCS HealthCare of KY, Inc dba Vangard Labs

Application

ANDA074823

Marketing category

ANDA

Marketing start

1998-03-30

Marketing end

0000-00-00

Substance

TERAZOSIN HYDROCHLORIDE

Active strength

2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]

NDC exclude flag

E

Listing certified through

2017-12-31

Current FDA listing

Historical FDA.report record